KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,841 | -62.0% | 36,715 | -55.9% | 0.01% | -65.2% |
| Q2 2023 | $881,557 | +20.3% | 83,323 | +55.3% | 0.02% | -11.5% |
| Q3 2022 | $733,000 | +102.5% | 53,641 | +171.3% | 0.03% | +62.5% |
| Q2 2022 | $362,000 | +87.6% | 19,775 | +43.6% | 0.02% | +33.3% |
| Q4 2021 | $193,000 | -19.2% | 13,768 | +7.9% | 0.01% | -36.8% |
| Q3 2021 | $239,000 | -52.4% | 12,760 | -47.0% | 0.02% | -54.8% |
| Q2 2021 | $502,000 | +129.2% | 24,056 | +210.0% | 0.04% | +110.0% |
| Q1 2021 | $219,000 | -70.0% | 7,760 | -65.3% | 0.02% | -74.0% |
| Q4 2020 | $731,000 | +163.9% | 22,375 | +31.6% | 0.08% | +305.3% |
| Q2 2020 | $277,000 | -10.4% | 17,001 | -45.3% | 0.02% | -13.6% |
| Q1 2020 | $309,000 | +82.8% | 31,086 | +153.5% | 0.02% | +120.0% |
| Q4 2019 | $169,000 | -22.1% | 12,261 | -1.1% | 0.01% | -37.5% |
| Q3 2018 | $217,000 | – | 12,396 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |